The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells
- PMID: 19383607
- PMCID: PMC2719341
- DOI: 10.1074/jbc.M109.010066
The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells
Abstract
The urokinase receptor (uPAR), expressed on the surface of many cell types, coordinates plasmin-mediated cell surface proteolysis for matrix remodeling and promotes cell adhesion by acting as a binding protein for vitronectin. There is great clinical interest in uPAR in the cancer field as numerous reports have demonstrated that up-regulation of the uPA system is correlated with malignancy of various carcinomas. Using both stable cell lines overexpressing uPAR and transient gene transfer, here we provide evidence for a non-reported role of uPAR in the phagocytosis of apoptotic cells, a process that has recently been termed efferocytosis. When uPAR was expressed in human embryonic kidney cells, hamster melanoma cells, or breast cancer cells (BCCs), there was a robust enhancement in the efferocytosis of apoptotic cells. uPAR-expressing cells failed to stimulate engulfment of viable cells, suggesting that uPAR enhances recognition of one or more determinant on the surface of the apoptotic cell. uPAR-mediated engulfment was not inhibited by expression of mutant beta5 integrin, nor was alphavbeta5 integrin-mediated engulfment modulated by cleavage of uPAR by phosphatidylinositol-specific phospholipase C. Further, we found that the more aggressive BCCs had a higher phagocytic capacity that correlated with uPAR expression and cleavage of membrane-associated uPAR in MDA-MB231 BCCs significantly impaired phagocytic activity. Because efferocytosis is critical for the resolution of inflammation and production of anti-inflammatory cytokines, overexpression of uPAR in tumor cells may promote a tolerogenic microenvironment that favors tumor progression.
Figures





Similar articles
-
High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.J Immunol. 2014 May 1;192(9):4398-408. doi: 10.4049/jimmunol.1302590. Epub 2014 Mar 31. J Immunol. 2014. PMID: 24688027 Free PMC article.
-
A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.ACS Chem Biol. 2015 Jun 19;10(6):1521-34. doi: 10.1021/cb500832q. Epub 2015 Mar 31. ACS Chem Biol. 2015. PMID: 25671694 Free PMC article.
-
Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.Thromb Haemost. 2006 Mar;95(3):524-34. doi: 10.1160/TH05-06-0457. Thromb Haemost. 2006. PMID: 16525582
-
Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398. Stem Cells. 1997. PMID: 9402652 Review.
-
[Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].Nihon Sanka Fujinka Gakkai Zasshi. 1996 Aug;48(8):623-32. Nihon Sanka Fujinka Gakkai Zasshi. 1996. PMID: 8808830 Review. Japanese.
Cited by
-
Apoptosis and apoptotic body: disease message and therapeutic target potentials.Biosci Rep. 2019 Jan 18;39(1):BSR20180992. doi: 10.1042/BSR20180992. Print 2019 Jan 31. Biosci Rep. 2019. PMID: 30530866 Free PMC article. Review.
-
High molecular weight kininogen binds phosphatidylserine and opsonizes urokinase plasminogen activator receptor-mediated efferocytosis.J Immunol. 2014 May 1;192(9):4398-408. doi: 10.4049/jimmunol.1302590. Epub 2014 Mar 31. J Immunol. 2014. PMID: 24688027 Free PMC article.
-
MFG-E8 expression for progression of oral squamous cell carcinoma and for self-clearance of apoptotic cells.Lab Invest. 2014 Nov;94(11):1260-72. doi: 10.1038/labinvest.2014.108. Epub 2014 Sep 29. Lab Invest. 2014. PMID: 25264705
-
The mannose 6-phosphate/insulin-like growth factor 2 receptor mediates plasminogen-induced efferocytosis.J Leukoc Biol. 2019 Mar;105(3):519-530. doi: 10.1002/JLB.1AB0417-160RR. Epub 2019 Jan 18. J Leukoc Biol. 2019. PMID: 30657605 Free PMC article.
-
Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA/Ro-bound apoptotic cardiocytes: Implications in the pathogenesis of congenital heart block.Circ Res. 2010 Aug 6;107(3):374-87. doi: 10.1161/CIRCRESAHA.109.213629. Epub 2010 Jun 17. Circ Res. 2010. PMID: 20558828 Free PMC article.
References
-
- Blasi F. ( 1993) Bioessays 15, 105– 111 - PubMed
-
- Rømer J., Bugge T. H., Pyke C., Lund L. R., Flick M. J., Degen J. L., Danø K. ( 1996) Nat. Med. 2, 725. - PubMed
-
- Romer J., Bugge T. H., Pyke C., Lund L. R., Flick M. J., Degen J. L., Dano K. ( 1996) Nat. Med. 2, 287– 292 - PubMed
-
- Saksela O., Rifkin D. B. ( 1988) Annu. Rev. Cell Biol. 4, 93– 126 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous